RICHARD JACONETTE: Open Payments
NPI 1578785432 · ROCKFORD, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,366 in 60 payments from 15 companies in 2025. Trend: 2023 $85 · 2024 $143 · 2025 $1,366
Food & beverage: $1,366
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $292 |
| Neurocrine BioSciences, Inc. | 6 | $166 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $129 |
| Otsuka America Pharmaceutical, Inc. | 4 | $119 |
| Teva Pharmaceuticals USA, Inc. | 5 | $109 |
| Axsome Therapeutics, Inc. | 3 | $84 |
| E.R. Squibb & Sons, L.L.C. | 3 | $83 |
| Lundbeck LLC | 4 | $81 |
| Alkermes, Inc. | 4 | $77 |
| Collegium Pharmaceutical, Inc. | 4 | $73 |
Products named: VRAYLAR, REXULTI, INGREZZA, CAPLYTA, AUSTEDO XR, Auvelity, COBENFY, Jornay PM.
Industry payments across IL — which companies pay providers there.
